Vanessa Sancho-Shimizu

Vanessa Sancho-Shimizu

Auto-generated profile, based on publicly available information

Vanessa Sancho-Shimizu

Department of Infectious Disease, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Trends in Molecular Medicine
Verified
Journal Article
Open access
LALiyana Ahmad
Liyana Ahmad
SZShen-Ying Zhang
Shen-Ying Zhang
JCJean-Laurent Casanova
Jean-Laurent Casanova
VSVanessa Sancho-Shimizu
Vanessa Sancho-Shimizu
The importance of TANK binding kinase-1 (TBK1), a multimeric kinase that modulates inflammation and autophagy, in human health has been highlighted for the first time by the recent discoveries of mutations in TBK1 that underlie amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), normal tension glaucoma (NTG) or childhood herpes simplex encephalitis (HSE). Gain-of-function of TBK1 are associated with NTG, whereas loss-of-function mutations result in ALS/FTD or in HSE. In light of these new findings, we review the role of TBK1 in these seemingly unrelated, yet allelic diseases, and discuss the role of TBK1 in neuroinflammatory diseases. This discovery has the potential to significantly increase our understanding of the molecular basis of these poorly understood diseases.

10 February 2023 in Science
Verified
Journal Article
Open access
DLDanyel Lee
Danyel Lee
JPJérémie Le Pen
Jérémie Le Pen
AYAhmad Yatim
Ahmad Yatim
BDBeihua Dong
Beihua Dong
YAYann Aquino
Yann Aquino
Gianvincenzo ZuccottiGianvincenzo Zuccotti
Gianvincenzo Zuccotti
Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that follows benign COVID-19. We report autosomal recessive deficiencies of OAS1 , OAS2 , or RNASEL in five unrelated children with MIS-C. The cytosolic double-stranded RNA (dsRNA)–sensing OAS1 and OAS2 generate 2′-5′-linked oligoadenylates (2-5A) that activate the single-stranded RNA–degrading ribonuclease L (RNase L). Monocytic cell lines and primary myeloid cells with OAS1, OAS2, or RNase L deficiencies produce excessive amounts of inflammatory cytokines upon dsRNA or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulation. Exogenous 2-5A suppresses cytokine production in OAS1-deficient but not RNase L–deficient cells. Cytokine production in RNase L–deficient cells is impaired by MDA5 or RIG-I deficiency and abolished by mitochondrial antiviral-signaling protein (MAVS) deficiency. Recessive OAS–RNase L deficiencies in these patients unleash the production of SARS-CoV-2–triggered, MAVS-mediated inflammatory cytokines by mononuclear phagocytes, thereby underlying MIS-C.

27 April 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
VSVanessa Sancho-Shimizu
Vanessa Sancho-Shimizu
PBPetter Brodin
Petter Brodin
ACAurélie Cobat
Aurélie Cobat
CBCatherine M. Biggs
Catherine M. Biggs
JTJulie Toubiana
Julie Toubiana
SZShen-Ying Zhang
Shen-Ying Zhang
Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in communities with high COVID-19 rates. This new condition is heterogenous but resembles Kawasaki disease (KD), a well-known but poorly understood and clinically heterogenous pediatric inflammatory condition for which weak associations have been found with a myriad of viral illnesses. Epidemiological data clearly indicate that SARS-CoV-2 is the trigger for MIS-C, which typically occurs about 1 mo after infection. These findings support the hypothesis of viral triggers for the various forms of classic KD. We further suggest that rare inborn errors of immunity (IEIs) altering the immune response to SARS-CoV-2 may underlie the pathogenesis of MIS-C in some children. The discovery of monogenic IEIs underlying MIS-C would shed light on its pathogenesis, paving the way for a new genetic approach to classic KD, revisited as a heterogeneous collection of IEIs to viruses.

19 November 2018 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
LALiyana Ahmad
Liyana Ahmad
SMSerge Mostowy
Serge Mostowy
VSVanessa Sancho-Shimizu
Vanessa Sancho-Shimizu
Autophagy is a highly conserved intracellular degradation process that targets protein aggregates and damaged organelles. Autophagy is also implicated in numerous viral infections, including human immunodeficiency virus-1 (HIV-1), influenza A (IAV) and herpes simplex virus-1 (HSV-1). Depending on the virus, autophagy can restrict or promote viral replication, and play key roles in modulating inflammation and cell survival. In this review, we consider examples of autophagy-virus interplay, highlighting the protective role of autophagy in human infections. We summarize recent discoveries and emerging themes illuminating autophagy’s role in immunity and inflammation upon viral infection. Finally, we discuss future prospects and therapeutic implications, and potential caveats associated with using autophagy to control viral infections in humans.

4 January 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
DGDaxing Gao
Daxing Gao
MCMichael J. Ciancanelli
Michael J. Ciancanelli
PZPeng Zhang
Peng Zhang
OHOliver Harschnitz
Oliver Harschnitz
VBVincent Bondet
Vincent Bondet
SZShen-Ying Zhang
Shen-Ying Zhang
Human herpes simplex virus 1 (HSV-1) encephalitis can be caused by inborn errors of the TLR3 pathway, resulting in impairment of CNS cell-intrinsic antiviral immunity. Deficiencies of the TLR3 pathway impair cell-intrinsic immunity to vesicular stomatitis virus (VSV) and HSV-1 in fibroblasts, and to HSV-1 in cortical but not trigeminal neurons. The underlying molecular mechanism is thought to involve impaired IFN-α/β induction by the TLR3 recognition of dsRNA viral intermediates or by-products. However, we show here that human TLR3 controls constitutive levels of IFNB mRNA and secreted bioactive IFN-β protein, and thereby also controls constitutive mRNA levels for IFN-stimulated genes (ISGs) in fibroblasts. Tlr3–/– mouse embryonic fibroblasts also have lower basal ISG levels. Moreover, human TLR3 controls basal levels of IFN-β secretion and ISG mRNA in induced pluripotent stem cell–derived cortical neurons. Consistently, TLR3-deficient human fibroblasts and cortical neurons are vulnerable not only to both VSV and HSV-1, but also to several other families of viruses. The mechanism by which TLR3 restricts viral growth in human fibroblasts and cortical neurons in vitro and, by inference, by which the human CNS prevents infection by HSV-1 in vivo, is therefore based on the control of early viral infection by basal IFN-β immunity.

18 December 2020 in Science Immunology
Verified
Journal Article
Closed access
AHAlon Schneider Hait
Alon Schneider Hait
David OlagnierDavid Olagnier
David Olagnier
VSVanessa Sancho-Shimizu
Vanessa Sancho-Shimizu
KSKristian Alsbjerg Skipper
Kristian Alsbjerg Skipper
MHMarie Helleberg
Marie Helleberg
TMTrine Mogensen
Trine Mogensen
Autophagy defects predispose to recurrent HSV2 meningitis and reveal an important role for autophagy in antiviral immunity.